retatrutide fda approval timeline Timeline: Week-by-Week Results (48 Weeks) Retatrutide - The Novel New

For some users, this translates to milder gastrointestinal side effects

Ill attach a table comparing stroke outcomes from major GLP-1 trials like SUSTAIN-6, REWIND, LEADER, and more

BNF NICE

Its going to start a new era of drug discovery. Cohen had little control over how his groundbreaking research would be used, however

Sandoz has been told its submission doesn't yet meet requirements and needs additional data pushing its expected launch from early 2026 to Q3 2026 at the earliest

Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients with Type 2 Diabetes Mellitus after 12-Month Treatment